Martine Walmsley

1.7k total citations · 2 hit papers
25 papers, 1.0k citations indexed

About

Martine Walmsley is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Martine Walmsley has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 13 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Martine Walmsley's work include Liver Diseases and Immunity (19 papers), Liver Disease Diagnosis and Treatment (13 papers) and Inflammatory Bowel Disease (8 papers). Martine Walmsley is often cited by papers focused on Liver Diseases and Immunity (19 papers), Liver Disease Diagnosis and Treatment (13 papers) and Inflammatory Bowel Disease (8 papers). Martine Walmsley collaborates with scholars based in United Kingdom, United States and Germany. Martine Walmsley's co-authors include Douglas Thorburn, Stephen P. Pereira, Gideon M. Hirschfield, Jessica Dyson, Graeme Alexander, Michael H. Chapman, Collette Thain, Imran Patanwala, Jane Collier and Richard J. Hall and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Martine Walmsley

22 papers receiving 991 citations

Hit Papers

Guidelines on the management of abnormal liver blood tests 2017 2026 2020 2023 2017 2021 100 200 300

Peers

Martine Walmsley
Ira Willner United States
Yücel Batur Türkiye
Iliana Doycheva United States
Eileen L. Yoon South Korea
Raza Malik United States
Ira Willner United States
Martine Walmsley
Citations per year, relative to Martine Walmsley Martine Walmsley (= 1×) peers Ira Willner

Countries citing papers authored by Martine Walmsley

Since Specialization
Citations

This map shows the geographic impact of Martine Walmsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Walmsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Walmsley more than expected).

Fields of papers citing papers by Martine Walmsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Walmsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Walmsley. The network helps show where Martine Walmsley may publish in the future.

Co-authorship network of co-authors of Martine Walmsley

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Walmsley. A scholar is included among the top collaborators of Martine Walmsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Walmsley. Martine Walmsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
High, Juliet, Matthew Hammond, Lee Shepstone, et al.. (2025). Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. BMJ Open Gastroenterology. 12(1). e001596–e001596.
2.
Kempski, Jan, et al.. (2025). PSC and colitis: A complex relationship. Hepatology. 82(4). 960–984. 1 indexed citations
3.
Hussain, Nasir, Christopher Ma, Gideon M. Hirschfield, et al.. (2024). Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis. BMJ Open. 14(6). e080143–e080143. 3 indexed citations
4.
Willemse, José, Martine Walmsley, Natalie Uhlenbusch, et al.. (2024). WED-158-YI Disease experience and care expectations in european patients with immune-mediated liver disease. Journal of Hepatology. 80. S712–S712. 1 indexed citations
5.
Rushbrook, Simon, Timothy J. Kendall, Yoh Zen, et al.. (2023). British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut. 73(1). 16–46. 33 indexed citations
6.
Hussain, Nasir, James Ferguson, Nadir Abbas, et al.. (2023). P34 Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study. Poster presentations. A34–A35.
7.
Walmsley, Martine, Dávid Tornai, Nora Cazzagon, et al.. (2023). Patient‐reported quality of care in primary sclerosing cholangitis. Liver International. 43(8). 1654–1662. 7 indexed citations
8.
Hussain, Nasir, James Ferguson, Nadir Abbas, et al.. (2023). Burden, impact and variability of pruritus in primary sclerosing cholangitis (PSC) over time: a prospective observational study. Journal of Hepatology. 78. S398–S399. 1 indexed citations
9.
Marcus, Elena, Patrick Stone, Douglas Thorburn, Martine Walmsley, & Bella Vivat. (2022). Quality of life (QoL) for people with primary sclerosing cholangitis (PSC): a pragmatic strategy for identifying relevant QoL issues for rare disease. Journal of Patient-Reported Outcomes. 6(1). 76–76. 4 indexed citations
10.
Kowdley, Kris V., et al.. (2022). Impact of pruritus in primary sclerosing cholangitis (PSC): a multinational survey. Journal of Hepatology. 77. S312–S313. 1 indexed citations
11.
Fatourou, Evangelia, Dominic King, Martine Walmsley, et al.. (2021). PMO-35 UK national audit on diagnosis and management of colitis in patients with primary sclerosing cholangitis. A94.2–A95. 1 indexed citations
12.
Francque, Sven, Giulio Marchesini, Achim Kautz, et al.. (2021). Non-alcoholic fatty liver disease: A patient guideline. JHEP Reports. 3(5). 100322–100322. 162 indexed citations breakdown →
13.
Ranieri, Veronica, Eilis Kennedy, Martine Walmsley, Douglas Thorburn, & Kathy McKay. (2020). The Primary Sclerosing Cholangitis (PSC) Wellbeing Study: Understanding psychological distress in those living with PSC and those who support them. PLoS ONE. 15(7). e0234624–e0234624. 13 indexed citations
14.
Chapman, Michael H., Douglas Thorburn, Gideon M. Hirschfield, et al.. (2019). British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 68(8). 1356–1378. 167 indexed citations
15.
Walmsley, Martine, et al.. (2019). FRI-062-Identifying research priorities in primary sclerosing cholangitis: Driving clinically meaningful change from the patients’ perspective. Journal of Hepatology. 70(1). e412–e413. 5 indexed citations
16.
Hirschfield, Gideon M., Jessica Dyson, Graeme Alexander, et al.. (2018). The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 67(9). 1568–1594. 202 indexed citations
17.
18.
Newsome, Philip N., R Cramb, Suzanne Davison, et al.. (2017). Guidelines on the management of abnormal liver blood tests. Gut. 67(1). 6–19. 340 indexed citations breakdown →
19.
Walmsley, Martine, et al.. (1999). The effect of cyclosporin A and tacrolimus on cultured human epithelial cells: the role of TGF-β. Transplantation Proceedings. 31(1-2). 1173–1173. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026